ConductScience.org, home

Paper33859356

Pharmacological and behavioral divergence of ketamine enantiomers: implications for abuse liability.

Bonaventura J and 13 others. Mol Psychiatry, 2021. Cited by 225 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Pharmacological and behavioral divergence of ketamine enantiomers: implications for abuse liability. Papers, record 33859356. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33859356

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pharmacological and behavioral divergence of ketamine enantiomers: implications for abuse liability.
PubMed
Journal
Mol Psychiatry
PubMed
Year
2021
PubMed
Publication types
Journal Article, Research Support, N.I.H., Intramural
PubMed
Citations, by iCite
225
iCite
Relative citation ratio, by iCite
17.4
iCite
Revised in PubMed
2025-05-30
PubMed

Authors14

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bonaventura JJordihttps://orcid.org/0000-0002-4745-0151
2Lam SSherry
3Carlton MMeghan
4Boehm MAMatthew A
5Gomez JLJuan L
6Solís OOscar
7Sánchez-Soto MMarta
8Morris PJPatrick J
9Fredriksson IIda
10Thomas CJCraig J
11Sibley DRDavid Rhttps://orcid.org/0000-0002-0624-962X
12Shaham YYavinhttps://orcid.org/0000-0002-8242-3319
13Zarate CA JrCarlos A
14Michaelides MMichaelhttps://orcid.org/0000-0003-0398-4917

Source PubMed

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Depressive Disorder, Treatment-ResistantMajor topic
KetamineMajor topic
Animals
Antidepressive Agents
Depression
Mice
Rats
Stereoisomerism

Source PubMed

Grants6

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
ZIA DA000069Intramural NIH HHSUnited StatesZIADA000069PubMed and NIHNIH RePORTER
ZIA DA000434Intramural NIH HHSUnited StatesZIADA000434PubMed and NIHNIH RePORTER
ZIA MH002927Intramural NIH HHSUnited StatesZIAMH002927PubMedNIH RePORTER
ZIA NS002263Intramural NIH HHSUnited StatesZIANS002263PubMed and NIHNIH RePORTER
ZIAMH002857NIHNIH RePORTER
ZIATR000042NIHNIH RePORTER

Comments and corrections2

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn PapersSource
Comment in34,006,965Unraveling the opioid actions of S-ketamine and R-ketamine: comment on Bonaventura et al.https://conductscience.org/library/papers/34006965PubMed
Comment in35,177,823Comments to pharmacological and behavioral divergence of ketamine enantiomers by Jordi Bonaventura et al.https://conductscience.org/library/papers/35177823PubMed

References68

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
110,686,270Antidepressant effects of ketamine in depressed patients.Biol Psychiatry2000https://conductscience.org/library/papers/10686270PubMed
220,679,587A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression.Arch Gen Psychiatry2010https://conductscience.org/library/papers/20679587PubMed
316,894,061A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.Arch Gen Psychiatry2006https://conductscience.org/library/papers/16894061PubMed
422,297,150Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial.Biol Psychiatry2012https://conductscience.org/library/papers/22297150PubMed
527,056,608A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression.Am J Psychiatry2016https://conductscience.org/library/papers/27056608PubMed
623,982,301Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial.Am J Psychiatry2013https://conductscience.org/library/papers/23982301PubMed
719,897,179Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression.Biol Psychiatry2010https://conductscience.org/library/papers/19897179PubMed
827,878,517Risks Associated with Misuse of Ketamine as a Rapid-Acting Antidepressant.Neurosci Bull2016https://conductscience.org/library/papers/27878517PubMed
923,882,190Brain damages in ketamine addicts as revealed by magnetic resonance imaging.Front Neuroanat2013https://conductscience.org/library/papers/23882190PubMed
1031,109,197A Word to the Wise About Intranasal Esketamine.Am J Psychiatry2019https://conductscience.org/library/papers/31109197PubMed
1126,327,690R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects.Transl Psychiatry2015https://conductscience.org/library/papers/26327690PubMed
1229,945,898Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms.Pharmacol Rev2018https://conductscience.org/library/papers/29945898PubMed
1327,807,158Ketamine: NMDA Receptors and Beyond.J Neurosci2016https://conductscience.org/library/papers/27807158PubMed
1421,692,801Potentiation of μ-opioid receptor-mediated signaling by ketamine.J Neurochem2011https://conductscience.org/library/papers/21692801PubMed
1520,358,363Role of kappa-opioid receptors in the effects of salvinorin A and ketamine on attention in rats.Psychopharmacology (Berl)2010https://conductscience.org/library/papers/20358363PubMed
166,086,884A novel phencyclidine analog interacts selectively with mu opioid receptors.J Pharmacol Exp Ther1984https://conductscience.org/library/papers/6086884PubMed
178,098,066Synthesis and biological evaluation of 1-[1-(2-benzo[b]thienyl)cyclohexyl]piperidine homologues at dopamine-uptake and phencyclidine- and sigma-binding sites.J Med Chem1993https://conductscience.org/library/papers/8098066PubMed
182,544,905Role of the aromatic group in the inhibition of phencyclidine binding and dopamine uptake by PCP analogs.Pharmacol Biochem Behav1989https://conductscience.org/library/papers/2544905PubMed
1915,852,061Dopamine receptor contribution to the action of PCP, LSD and ketamine psychotomimetics.Mol Psychiatry2005https://conductscience.org/library/papers/15852061PubMed
2021,069,515Ketamine self-administration in the rat: evidence for a critical role of setting.Psychopharmacology (Berl)2011https://conductscience.org/library/papers/21069515PubMed

See all 68 references

Cited by139

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 225 citations.

PMIDTitleJournalYearIn PapersSource
42,985,291Integrating multi-receptor and neuron-glia mechanisms of ketamine's antidepressant action: a convergence framework for understanding efficacy.Front Mol Neurosci2026https://conductscience.org/library/papers/42985291PubMed
42,803,524Multimodal predictors of response to intravenous ketamine in treatment-resistant depression: toward personalized treatment in major depressive and bipolar disorders.CNS Spectr2026https://conductscience.org/library/papers/42803524PubMed
42,706,419Is (S)-norketamine an active mediator of esketamine's antidepressant effects?Mol Psychiatry2026https://conductscience.org/library/papers/42706419PubMed
42,637,972Molecular snapshots confirm ketamine's opioid nature.Nat Struct Mol Biol2026https://conductscience.org/library/papers/42637972PubMed
42,494,734Treating addiction with an addictive drug: the ketamine paradox revisited.Front Psychiatry2026https://conductscience.org/library/papers/42494734PubMed
42,332,075Structural basis of opioid receptor activation by PCP and ketamine.Nat Struct Mol Biol2026https://conductscience.org/library/papers/42332075PubMed
42,244,822The role of esketamine in enhancing postoperative recovery and pain management in laparoscopic surgery: a meta-analysis of randomised controlled trials.Eur J Anaesthesiol Intensive Care2026https://conductscience.org/library/papers/42244822PubMed
42,138,352Drug-induced changes in connectivity to midbrain dopamine cells revealed by rabies monosynaptic tracing.Elife2026https://conductscience.org/library/papers/42138352PubMed
42,098,542Restorative or Disruptive? Effects of Antidepressants on Sleep Architecture in Depression.CNS Drugs2026https://conductscience.org/library/papers/42098542PubMed
42,066,082TrkB/mGluR5 cross-talk underlies a synaptic metaplasticity mechanism of ketamine.Sci Adv2026https://conductscience.org/library/papers/42066082PubMed
42,030,928Mechanism-guided identification of antidepressant G protein-coupled receptor drug targets.Cell2026https://conductscience.org/library/papers/42030928PubMed
42,011,089Ketamine addiction following a single sub-anaesthetic ketamine treatment for acute suicidality in a psychiatrically multimorbid patient: case report.BJPsych Open2026https://conductscience.org/library/papers/42011089PubMed
41,974,884Pleiotropic modulation of the gut-brain-lung axis by ketamine and its enantiomers.Mol Psychiatry2026https://conductscience.org/library/papers/41974884PubMed
41,968,009Serotonergic and glutamatergic mechanisms converge in ketamine's rapid responses.Trends Neurosci2026https://conductscience.org/library/papers/41968009PubMed
41,929,866Ketamine and its two enantiomers in anesthesiology and psychiatry: A historical review and future directions.J Anesth Transl Med2024https://conductscience.org/library/papers/41929866PubMed
41,922,775A µ-opioid receptor superagonist analgesic with minimal adverse effects.Nature2026https://conductscience.org/library/papers/41922775PubMed
41,905,327Evaluation of optimal dosage combinations of oral midazolam and esketamine for pediatric preoperative sedation: A randomized, double-blind clinical trial.Clinics (Sao Paulo)2026https://conductscience.org/library/papers/41905327PubMed
41,887,688[Esketamine alleviates depression-like behaviors in mice with chronic restraint stress by activating glutamatergic neurons in the medial prefrontal cortex].Nan Fang Yi Ke Da Xue Xue Bao2026https://conductscience.org/library/papers/41887688PubMed
41,825,507Disruption of psychostimulant-associated memories by single, low dose ketamine in rats.Neuropharmacology2026https://conductscience.org/library/papers/41825507PubMed
41,648,568Negative allosteric modulation of α5-GABAA receptors engages dynamic cortical glutamatergic and GABAergic mechanisms underlying adaptive behavior in mice.bioRxiv2026https://conductscience.org/library/papers/41648568PubMed

See all 139 cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
OPRK14,986PubTator's text mininghttps://conductscience.org/library/genes/4986NCBI Gene
OPRM14,988PubTator's text mininghttps://conductscience.org/library/genes/4988NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33859356

GET https://conductscience.org/api/papers/v1/33859356/references?page=2